Concepedia

Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer

Alan N. Gordon, Michael Teneriello, Mike F. Janicek, Jeffrey F. Hines, Peter Lim, M. Dwight Chen, Luis Vaccarello, Howard D. Homesley, Scott McMeekin, Tiana L. Burkholder,

Gynecologic Oncology · 2011 · 26 citations · 24 references

Concepts

MedicineOncologyPharmacologyChemotherapyGynecologic OncologyMedical OncologyAdjuvant ChemotherapyCombination Cancer TherapyCombination ChemotherapyMalignant NeoplasmsOvarian CancerOvarian NeoplasiaMalignant Ovarian NeoplasmsOvarian Cancer Adjuvant TherapyOvarian Cancer ChemotherapyOvarian Cancer Clinical TrialsOvarian Cancer TreatmentOxaliplatin-based Therapy

References

24

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 7.8K citations

Public Health, Biostatistics, Mathematics +10

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

Andreas du Bois · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +17